GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: RG7112 is a clinical small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket. In cancer cells expressing wild-type p53, this compound stabilizes it and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumour xenografts [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone |
Database Links ![]() |
|
| ChEMBL Ligand | CHEMBL2386346 |
| GtoPdb PubChem SID | 340590229 |
| PubChem CID | 57406853 |
| RCSB PDB Ligand | 1F0 |
| Search Google for chemical match using the InChIKey | QBGKPEROWUKSBK-QPPIDDCLSA-N |
| Search Google for chemicals with the same backbone | QBGKPEROWUKSBK |
| UniChem Compound Search for chemical match using the InChIKey | QBGKPEROWUKSBK-QPPIDDCLSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | QBGKPEROWUKSBK-QPPIDDCLSA-N |
| Wikipedia | Q27287118 |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
RG7112 (links to external site)
Cat. No. HY-10959 |